Addus HomeCare Corporation (NASDAQ:ADUS) Receives Consensus Rating of "Buy" from Analysts

Shares of Addus HomeCare Corporation (NASDAQ:ADUS - Get Free Report) have received an average recommendation of "Buy" from the eight analysts that are presently covering the stock, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is $142.57.

Several analysts recently commented on ADUS shares. JMP Securities reaffirmed a "market outperform" rating and set a $150.00 price objective on shares of Addus HomeCare in a research note on Wednesday. Wall Street Zen upgraded Addus HomeCare from a "hold" rating to a "buy" rating in a report on Sunday, June 29th. Finally, Macquarie restated an "outperform" rating and issued a $133.00 price objective on shares of Addus HomeCare in a report on Tuesday, June 10th.

Addus HomeCare Trading Down 2.4%

ADUS stock opened at $107.03 on Friday. The firm has a market cap of $1.97 billion, a P/E ratio of 24.16, a P/E/G ratio of 1.52 and a beta of 0.81. Addus HomeCare has a 1-year low of $88.96 and a 1-year high of $136.72. The business's 50 day moving average is $112.44 and its 200-day moving average is $109.91. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.20.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings data on Monday, May 5th. The company reported $1.42 EPS for the quarter, beating analysts' consensus estimates of $1.33 by $0.09. The firm had revenue of $337.71 million for the quarter, compared to analyst estimates of $341.66 million. Addus HomeCare had a return on equity of 9.23% and a net margin of 6.52%. The business's quarterly revenue was up 20.3% compared to the same quarter last year. During the same period last year, the company earned $1.21 EPS. Equities analysts anticipate that Addus HomeCare will post 4.59 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Addus HomeCare news, EVP Michael D. Wattenbarger sold 2,045 shares of the business's stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $115.00, for a total transaction of $235,175.00. Following the sale, the executive vice president owned 7,796 shares of the company's stock, valued at approximately $896,540. The trade was a 20.78% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 4.60% of the stock is currently owned by corporate insiders.

Institutional Trading of Addus HomeCare

A number of institutional investors have recently bought and sold shares of ADUS. Natixis raised its holdings in shares of Addus HomeCare by 111.9% during the fourth quarter. Natixis now owns 250 shares of the company's stock valued at $31,000 after purchasing an additional 132 shares during the period. BI Asset Management Fondsmaeglerselskab A S bought a new position in shares of Addus HomeCare during the 1st quarter valued at approximately $41,000. Meeder Asset Management Inc. bought a new position in shares of Addus HomeCare during the 4th quarter valued at approximately $77,000. Harvest Fund Management Co. Ltd bought a new position in Addus HomeCare in the 4th quarter worth approximately $86,000. Finally, Caitong International Asset Management Co. Ltd boosted its holdings in Addus HomeCare by 368.3% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 1,255 shares of the company's stock worth $124,000 after buying an additional 987 shares during the period. Institutional investors own 95.35% of the company's stock.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.